腫瘤營養市場 - 全球產業規模、佔有率、趨勢、機會和預測，按癌症類型、營養成分、配方、配銷通路、最終用戶、地區和競爭細分，2020-2030 年

2024 年全球腫瘤營養市場價值達 25.3 億美元，預計到 2030 年將達到 41 億美元，預測期內複合年成長率為 8.35%。由於全球癌症負擔不斷增加、臨床對營養作為腫瘤治療計劃關鍵組成部分的認可度不斷提高，以及向以患者為中心的整體醫療服務轉變，這一市場正在經歷動態擴張。腫瘤營養曾經被視為一種補充措施，如今在多學科治療方法中發揮著至關重要的作用。這種演變受到疾病特異性配方使用增加、護理途徑中營養的機構標準化以及以患者特定代謝需求為指導的精準營養的推動。營養輸送和即時健康監測的技術創新使得更有效的干涉成為可能並推動了產品開發。隨著營養支持與更好的治療結果之間的聯繫變得更加明確，市場正在從一般的營養支持轉向基於證據的治療解決方案。這為尋求改善臨床療效、提高成本效率和改善癌症患者生活品質的現有企業和新興創新者創造了巨大的成長潛力。

關鍵市場促進因素

全球癌症發病率和死亡率飆升

主要市場挑戰

監理複雜性

主要市場趨勢

營養基因體學的興起

目錄

第 1 章：產品概述

第2章：研究方法

第3章：執行摘要

第4章：顧客之聲

第5章：腫瘤營養市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 依癌症類型（肺癌、頭頸癌、胃腸癌、食道癌、肝癌、血癌、其他）
  • 依營養（腸內營養、腸外營養）
  • 按配方（標準配方、元素配方、特殊配方）
  • 按配銷通路（醫院藥房、網路藥房、零售藥房）
  • 按最終使用者（醫院、家庭護理、專科診所）
  • 按地區
  • 按公司分類（2024）
• 市場地圖

第6章：北美腫瘤營養市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 美國
  • 加拿大
  • 墨西哥

第7章：歐洲腫瘤營養市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 德國
  • 英國
  • 義大利
  • 法國
  • 西班牙

第8章：亞太腫瘤營養市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 中國
  • 印度
  • 日本
  • 韓國
  • 澳洲

第9章：南美洲腫瘤營養市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 巴西
  • 阿根廷
  • 哥倫比亞

第10章：中東與非洲腫瘤營養市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 南非
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 最新動態
• 產品發布
• 併購

第 13 章：全球腫瘤營養市場：SWOT 分析

第 14 章：競爭格局

• Abbott Laboratories Inc
• Nestle SA
• Fresenius Kabi AG
• B Braun SE
• Hormel Foods Corporation
• Danone SA
• MEIJI Holdings Co Ltd
• Global Health Products, Inc.
• Victus Inc
• Mead Johnson & Co LLC

第 15 章：策略建議

第16章調查會社について,免責事項

The Global Oncology Nutrition Market reached a value of USD 2.53 billion in 2024 and is projected to attain USD 4.10 billion by 2030, growing at a CAGR of 8.35% during the forecast period. This market is undergoing dynamic expansion fueled by the increasing global cancer burden, the heightened clinical recognition of nutrition as a key component in oncology treatment plans, and the transition toward holistic, patient-focused care delivery. Once seen as a supplementary practice, oncology nutrition now plays an essential role in multidisciplinary treatment approaches. This evolution is being propelled by the increased use of disease-specific formulations, institutional standardization of nutrition in care pathways, and precision nutrition guided by patient-specific metabolic needs. Technological innovations in nutrient delivery and real-time health monitoring are enabling more effective interventions and advancing product development. As the link between nutritional support and better treatment outcomes becomes more substantiated, the market is shifting from general nutritional support to evidence-based, therapeutic solutions. This creates substantial growth potential for established players and emerging innovators seeking to deliver enhanced clinical outcomes, cost efficiency, and improved quality of life for cancer patients.

Key Market Drivers

Surging Global Cancer Incidence and Mortality

The increasing global incidence and mortality rates associated with cancer are primary growth drivers for the oncology nutrition market. In 2022, around 20 million new cancer cases and 9.7 million cancer-related deaths were reported, emphasizing the urgent need for supportive care solutions. Approximately 53.5 million individuals were living within five years of a cancer diagnosis, reflecting both improved survival and growing disease prevalence. Lifestyle-related risk factors-such as poor diet, sedentary habits, smoking, and alcohol consumption-as well as aging populations, continue to elevate cancer incidence, particularly in developed regions. Individuals aged 60-69 are four times more likely to be diagnosed with cancer than those under 50, while those over 70 face a tenfold increase in risk. The rising number of cancer diagnoses is directly increasing demand for comprehensive treatment support, including specialized nutritional interventions that can aid in managing side effects, boosting recovery, and enhancing treatment adherence.

Key Market Challenges

Regulatory Complexity

The oncology nutrition sector faces regulatory hurdles due to diverse and complex standards governing product development, labeling, and distribution across regions. Regulations vary significantly by country, and navigating this fragmented regulatory landscape is time-consuming and resource-intensive. Global companies must invest heavily in compliance to meet these evolving regulatory requirements, which can slow innovation and market expansion.

Key Market Trends

Rise of Nutrigenomics

Nutrigenomics-the study of how an individual's genetic makeup influences their response to nutrients-is gaining momentum in oncology nutrition. This approach enables highly personalized dietary plans that align with a patient's unique genetic and metabolic profile. It has the potential to revolutionize cancer care by improving treatment effectiveness, minimizing side effects, and enhancing overall outcomes through customized nutritional strategies rooted in precision medicine.

Key Market Players

• Abbott Laboratories Inc
• Nestle SA
• Fresenius Kabi AG
• B Braun SE
• Hormel Foods Corporation
• Danone SA
• MEIJI Holdings Co Ltd
• Global Health Products, Inc.
• Victus Inc
• Mead Johnson & Co LLC

Report Scope:

In this report, the Global Oncology Nutrition Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Oncology Nutrition Market, By Cancer Type:

• Lung Cancer
• Head and Neck Cancer
• Stomach and Gastrointestinal Cancers
• Esophageal Cancer
• Liver Cancer
• Blood Cancer
• Others

Oncology Nutrition Market, By Nutrition:

• Enteral Nutrition
• Parenteral Nutrition

Oncology Nutrition Market, By Formula:

• Standard Formula
• Elemental Formula
• Specialized Formula

Oncology Nutrition Market, By Distribution Channel:

• Hospital Pharmacy
• Online Pharmacy
• Retail Pharmacy

Oncology Nutrition Market, By End User:

• Hospitals
• Homecare
• Specialty Clinics

Oncology Nutrition Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Oncology Nutrition Market.

Available Customizations:

Global Oncology Nutrition Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Oncology Nutrition Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Cancer Type (Lung Cancer, Head and Neck Cancer, Stomach and Gastrointestinal Cancers, Esophageal Cancer, Liver Cancer, Blood Cancer, Others)
  • 5.2.2. By Nutrition (Enteral Nutrition, Parenteral Nutrition)
  • 5.2.3. By Formula (Standard Formula, Elemental Formula, Specialized Formula)
  • 5.2.4. By Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
  • 5.2.5. By End User (Hospitals, Homecare, Specialty Clinics)
  • 5.2.6. By Region
  • 5.2.7. By Company (2024)
• 5.3. Market Map

6. North America Oncology Nutrition Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Cancer Type
  • 6.2.2. By Nutrition
  • 6.2.3. By Formula
  • 6.2.4. By Distribution Channel
  • 6.2.5. By End User
  • 6.2.6. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Oncology Nutrition Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Cancer Type
      • 6.3.1.2.2. By Nutrition
      • 6.3.1.2.3. By Formula
      • 6.3.1.2.4. By Distribution Channel
      • 6.3.1.2.5. By End User
  • 6.3.2. Canada Oncology Nutrition Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Cancer Type
      • 6.3.2.2.2. By Nutrition
      • 6.3.2.2.3. By Formula
      • 6.3.2.2.4. By Distribution Channel
      • 6.3.2.2.5. By End User
  • 6.3.3. Mexico Oncology Nutrition Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Cancer Type
      • 6.3.3.2.2. By Nutrition
      • 6.3.3.2.3. By Formula
      • 6.3.3.2.4. By Distribution Channel
      • 6.3.3.2.5. By End User

7. Europe Oncology Nutrition Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Cancer Type
  • 7.2.2. By Nutrition
  • 7.2.3. By Formula
  • 7.2.4. By Distribution Channel
  • 7.2.5. By End User
  • 7.2.6. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Oncology Nutrition Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Cancer Type
      • 7.3.1.2.2. By Nutrition
      • 7.3.1.2.3. By Formula
      • 7.3.1.2.4. By Distribution Channel
      • 7.3.1.2.5. By End User
  • 7.3.2. United Kingdom Oncology Nutrition Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Cancer Type
      • 7.3.2.2.2. By Nutrition
      • 7.3.2.2.3. By Formula
      • 7.3.2.2.4. By Distribution Channel
      • 7.3.2.2.5. By End User
  • 7.3.3. Italy Oncology Nutrition Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Cancer Type
      • 7.3.3.2.2. By Nutrition
      • 7.3.3.2.3. By Formula
      • 7.3.3.2.4. By Distribution Channel
      • 7.3.3.2.5. By End User
  • 7.3.4. France Oncology Nutrition Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Cancer Type
      • 7.3.4.2.2. By Nutrition
      • 7.3.4.2.3. By Formula
      • 7.3.4.2.4. By Distribution Channel
      • 7.3.4.2.5. By End User
  • 7.3.5. Spain Oncology Nutrition Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Cancer Type
      • 7.3.5.2.2. By Nutrition
      • 7.3.5.2.3. By Formula
      • 7.3.5.2.4. By Distribution Channel
      • 7.3.5.2.5. By End User

8. Asia-Pacific Oncology Nutrition Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Cancer Type
  • 8.2.2. By Nutrition
  • 8.2.3. By Formula
  • 8.2.4. By Distribution Channel
  • 8.2.5. By End User
  • 8.2.6. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Oncology Nutrition Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Cancer Type
      • 8.3.1.2.2. By Nutrition
      • 8.3.1.2.3. By Formula
      • 8.3.1.2.4. By Distribution Channel
      • 8.3.1.2.5. By End User
  • 8.3.2. India Oncology Nutrition Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Cancer Type
      • 8.3.2.2.2. By Nutrition
      • 8.3.2.2.3. By Formula
      • 8.3.2.2.4. By Distribution Channel
      • 8.3.2.2.5. By End User
  • 8.3.3. Japan Oncology Nutrition Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Cancer Type
      • 8.3.3.2.2. By Nutrition
      • 8.3.3.2.3. By Formula
      • 8.3.3.2.4. By Distribution Channel
      • 8.3.3.2.5. By End User
  • 8.3.4. South Korea Oncology Nutrition Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Cancer Type
      • 8.3.4.2.2. By Nutrition
      • 8.3.4.2.3. By Formula
      • 8.3.4.2.4. By Distribution Channel
      • 8.3.4.2.5. By End User
  • 8.3.5. Australia Oncology Nutrition Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Cancer Type
      • 8.3.5.2.2. By Nutrition
      • 8.3.5.2.3. By Formula
      • 8.3.5.2.4. By Distribution Channel
      • 8.3.5.2.5. By End User

9. South America Oncology Nutrition Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Cancer Type
  • 9.2.2. By Nutrition
  • 9.2.3. By Formula
  • 9.2.4. By Distribution Channel
  • 9.2.5. By End User
  • 9.2.6. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Oncology Nutrition Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Therapy
  • 9.3.2. Argentina Oncology Nutrition Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Cancer Type
      • 9.3.2.2.2. By Nutrition
      • 9.3.2.2.3. By Formula
      • 9.3.2.2.4. By Distribution Channel
      • 9.3.2.2.5. By End User
  • 9.3.3. Colombia Oncology Nutrition Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Cancer Type
      • 9.3.3.2.2. By Nutrition
      • 9.3.3.2.3. By Formula
      • 9.3.3.2.4. By Distribution Channel
      • 9.3.3.2.5. By End User

10. Middle East and Africa Oncology Nutrition Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Cancer Type
  • 10.2.2. By Nutrition
  • 10.2.3. By Formula
  • 10.2.4. By Distribution Channel
  • 10.2.5. By End User
  • 10.2.6. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Oncology Nutrition Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Cancer Type
      • 10.3.1.2.2. By Nutrition
      • 10.3.1.2.3. By Formula
      • 10.3.1.2.4. By Distribution Channel
      • 10.3.1.2.5. By End User
  • 10.3.2. Saudi Arabia Oncology Nutrition Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Cancer Type
      • 10.3.2.2.2. By Nutrition
      • 10.3.2.2.3. By Formula
      • 10.3.2.2.4. By Distribution Channel
      • 10.3.2.2.5. By End User
  • 10.3.3. UAE Oncology Nutrition Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Cancer Type
      • 10.3.3.2.2. By Nutrition
      • 10.3.3.2.3. By Formula
      • 10.3.3.2.4. By Distribution Channel
      • 10.3.3.2.5. By End User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Developments
• 12.2. Product Launches
• 12.3. Mergers & Acquisitions

13. Global Oncology Nutrition Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Abbott Laboratories Inc
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Nestle SA
• 14.3. Fresenius Kabi AG
• 14.4. B Braun SE
• 14.5. Hormel Foods Corporation
• 14.6. Danone SA
• 14.7. MEIJI Holdings Co Ltd
• 14.8. Global Health Products, Inc.
• 14.9. Victus Inc
• 14.10.Mead Johnson & Co LLC

15. Strategic Recommendations

16. About Us & Disclaimer